Growth Metrics

Pulmonx (LUNG) Non-Current Debt (2020 - 2025)

Pulmonx has reported Non-Current Debt over the past 6 years, most recently at $37.0 million for Q4 2025.

  • Quarterly Non-Current Debt rose 8.78% to $37.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.0 million through Dec 2025, up 8.78% year-over-year, with the annual reading at $37.0 million for FY2025, 8.78% up from the prior year.
  • Non-Current Debt was $37.0 million for Q4 2025 at Pulmonx, roughly flat from $37.0 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $37.2 million in Q1 2023 and troughed at $179000.0 in Q4 2021.
  • The 5-year median for Non-Current Debt is $33.0 million (2024), against an average of $24.5 million.
  • Year-over-year, Non-Current Debt tumbled 68.26% in 2021 and then skyrocketed 9527.93% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $179000.0 in 2021, then skyrocketed by 9527.93% to $17.2 million in 2022, then surged by 103.6% to $35.1 million in 2023, then fell by 3.1% to $34.0 million in 2024, then increased by 8.78% to $37.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non-Current Debt are $37.0 million (Q4 2025), $37.0 million (Q3 2025), and $37.0 million (Q2 2025).